Wikipedia
Linking
Google
Scholar Search
Drug
Information Portal (U.S. National Library of Medicine) - Capecitabine
PubChem
Compound
Summary
- Capecitabine
Drug
Bank - Capecitabine
KEGG
(Kyoto Encyclopedia of Genes and Genomes) - Capecitabine
http://www.ebi.ac.uk/chebi/
- Capecitabine
http://www.ncbi.nlm.nih.gov/
- Capecitabine
http://www.cancer.gov/ capecitabine:
A fluoropyrimidine carbamate belonging to the class
of antineoplastic agents called antimetabolites. As
a prodrug, capecitabine is selectively activated by
tumor cells to its cytotoxic moiety, 5-fluorouracil
(5-FU); subsequently, 5-FU is metabolized to two active
metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP)
and 5-fluorouridine triphosphate (FUTP) by both tumor
cells and normal cells. FdUMP inhibits DNA synthesis
and cell division by reducing normal thymidine production,
while FUTP inhibits RNA and protein synthesis by competing
with uridine triphosphate for incorporation into the
RNA strand. Check for active clinical trials or closed
clinical trials using this agent
http://drugsarea.com/ Mechanism
of Action: Capecitabine is a prodrug of fluorouracil.
It undergoes hydrolysis in the liver and tissues to
form fluorouracil which is the active moiety. Fluorouracil
is a fluorinated pyrimidine antimetabolite that inhibits
thymidylate synthetase, blocking the methylation of
deoxyuridylic acid to thymidylic acid, interfering with
DNA, and to a lesser degree, RNA synthesis. Fluorouracil
appears to be phase specific for the G1 and S phases
of the cell cycle.
|